IOL Chemicals and Pharmaceuticals share news and announcements
NSE: IOLCPBSE: 524164Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹171.36.
- Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 30 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹4,818 Cr1,024th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 10 Aug 2026
- 28.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 20 May 2026
- 2.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.61%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 10 Aug 2026
- 9.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 10 Aug 2026
- 11.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 20 May 2026
- 0.07
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 31,10,55637.2% delivered
IOL Chemicals and Pharmaceuticals routine notices
307 filed, newest first. Page 2 of 7.
Sep 2024
27 Sep · Routine
9 Sep · Routine
6 Sep · Routine
Aug 2024
28 Aug · Routine
12 Aug · Routine
6 Aug · Routine
2 Aug · Routine
Jul 2024
30 Jul · Routine
24 Jul · Routine
10 Jul · Routine
10 Jul · Routine
Jun 2024
18 Jun · Routine
14 Jun · Routine
5 Jun · Routine
May 2024
24 May · Routine
24 May · Routine
20 May · Routine
18 May · Routine
15 May · Routine
Apr 2024
26 Apr · Routine
24 Apr · Routine
Mar 2024
Feb 2024
13 Feb · Routine
7 Feb · Routine
Jan 2024
25 Jan · Routine
2 Jan · Routine
Dec 2023
19 Dec · Routine
6 Dec · Routine
Nov 2023
29 Nov · Routine
10 Nov · Routine
9 Nov · Routine
Oct 2023
31 Oct · Routine
11 Oct · Routine
4 Oct · Routine
Sep 2023
14 Sep · Routine
12 Sep · Routine
Aug 2023
25 Aug · Routine
16 Aug · Routine
10 Aug · Routine
Jul 2023
29 Jul · Routine
28 Jul · Routine
25 Jul · Routine